Broome Oncology

Cervical Cancer News

Questions to Ask Before Radiation Therapy for the Treatment of Cervical Cancer (December 13, 2017)

Radiation therapy, or radiotherapy, is a common way to treat cervical cancer. Doctors who specialize in treating cancers with radiation are known as radiation oncologists. During radiation therapy, high-energy x-rays are used to kill cancer cells. Radiation... Continue Reading

Managment of the Side Effects of Radiation for Cervical Cancer (December 7, 2017)

Radiation therapy, or radiotherapy, is a common way to treat cervical cancer. With any treatment of cancer you must first understand your responsibility and your medical team’s role as well as explore treatment options and get a second opinion(s) before... Continue Reading

What You Should Know About the Side Effects of Surgery for Cervical Cancer (December 6, 2017)

A hysterectomy is a common surgical treatment of early stage cancer and precancerous disease of the cervix in women. With any treatment of cancer it is important to first understand your responsibility and your medical team’s role as well as explore... Continue Reading

Cervical Cancer Survivors Frequently Suffer From Long-Term Side Effects of Treatment (August 17, 2017)

According to a new study around half of women who have been treated for locally advanced cervical cancer suffer from symptoms of insomnia, fatigue or hot flushes.1 Cervical cancer affects more than 500,000 women around the world each year with an average... Continue Reading

Genmab Announces Preliminary Cervical Cancer Data from Tisotumab Vedotin Phase I/II Study (July 5, 2017)

Data from an ongoing clinical study of tisotumab vedotin in solid tumors has demonstrated activity in the treatment of cervical cancer; 11 of 34 evaluable patients achieved a response; with a median time of treatment of 4.9 months and 7 responders are... Continue Reading

Immune Therapy Produces Anti-Cancer Responses in Advanced Cervical Cancer (April 24, 2017)

Adoptive T-cell therapy (ACT) appears to provide anti-cancer responses among patients with advanced cervical cancer for whom standard therapy has stopped working. These results were published in the Journal of Clinical Oncology. The most common cause... Continue Reading

Nearly half of U.S. men actively infected with HPV, study finds HPV-linked cancers on the rise in men, but nearly 9 in 10 vaccine-eligible men are unvaccinated! (February 20, 2017)

By Rachel Tompa / Fred Hutch News Service The most common sexually transmitted infection in the U.S. has a bit of a twist. It’s what’s known as a “subclinical infection” — those infected suffer no immediate consequences, but years later have... Continue Reading

The HPV Vaccine Prevents Lesions That Could Cause Cervical Cancer by 50 Percent (October 13, 2016)

A recent report published online Sept. 29 in the journal JAMA Oncology suggests that the vaccine against human papillomavirus (HPV) infection, which doctors believe causes most cases of cervical cancer, is more effective than previously thought. Human... Continue Reading

HPV Testing Found to Be More Effective Than Pap Smears in Evaluating Cervical Cancer Risk (July 23, 2014)

Researchers at the National Cancer Institute reported that testing for HPV (human papillomavirus) is the most effective way to determine whether a woman is at risk for developing cervical cancer in the near future. Specifically, the study found that negative... Continue Reading

Gardasil Provides Poor Protection in Women Over 18 (February 3, 2014)

A significant percentage of women vaccinated with Gardasil® (quadrivalent human papillomavirus recombinant vaccine) may not be protected against high-grade squamous intraepithelial lesions (HSIL) and lesser dysplasia—especially if they were vaccinated... Continue Reading

Latest Cervical Cancer News By Stage


Metastatic/Stage IVB Cervical Cancer

Avastin Improves Outcomes for Women with Advanced Cervical Cancer (June 11, 2013)

In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading

January Is National Cervical Cancer Awareness Month (January 5, 2010)

As the month of January brings cervical cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated cervical cancer... Continue Reading

More Metastatic/Stage IVB Cervical Cancer

Recurrent Cervical Cancer

Avastin Improves Outcomes for Women with Advanced Cervical Cancer (June 11, 2013)

In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading

January Is National Cervical Cancer Awareness Month (January 5, 2010)

As the month of January brings cervical cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated cervical cancer... Continue Reading

More Recurrent Cervical Cancer

Screening/Prevention Cervical Cancer

The HPV Vaccine Prevents Lesions That Could Cause Cervical Cancer by 50 Percent (October 13, 2016)

A recent report published online Sept. 29 in the journal JAMA Oncology suggests that the vaccine against human papillomavirus (HPV) infection, which doctors believe causes most cases of cervical cancer, is more effective than previously thought. Human... Continue Reading

HPV Testing Found to Be More Effective Than Pap Smears in Evaluating Cervical Cancer Risk (July 23, 2014)

Researchers at the National Cancer Institute reported that testing for HPV (human papillomavirus) is the most effective way to determine whether a woman is at risk for developing cervical cancer in the near future. Specifically, the study found that negative... Continue Reading

Gardasil Provides Poor Protection in Women Over 18 (February 3, 2014)

A significant percentage of women vaccinated with Gardasil® (quadrivalent human papillomavirus recombinant vaccine) may not be protected against high-grade squamous intraepithelial lesions (HSIL) and lesser dysplasia—especially if they were vaccinated... Continue Reading

Younger Girls May Need Fewer Gardasil Shots (June 26, 2013)

Two doses of the human papillomavirus (HPV) vaccine Gardasil may be just as effective in younger girls (preteens) as the recommended three doses given to older teens, according to the results of a study published in the Journal of the American Medical... Continue Reading

HPV Test Appropriate After Indeterminate Pap Test (April 29, 2013)

Women who have an indeterminate Pap smear should undergo human papillomavirus (HPV) testing rather than another Pap smear, according to the results of Cochrane Review. Cancer screening refers to the use of tests to detect cancer in individuals who do... Continue Reading

More Screening/Prevention Cervical Cancer

Stage I Cervical Cancer

Sorry, there are no articles available for this cancer stage.

More Stage I Cervical Cancer

Stages II-IVA Cervical Cancer

Study Evaluates Incidence of Lymphedema Resulting from Cancer Treatment (August 9, 2010)

A systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases. These findings were recently... Continue Reading

January Is National Cervical Cancer Awareness Month (January 5, 2010)

As the month of January brings cervical cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated cervical cancer... Continue Reading

More Stages II-IVA Cervical Cancer